# The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV

> **NCT06635421** · — · NOT_YET_RECRUITING · sponsor: **MetroHealth Medical Center** · enrollment: 164 (estimated)

## Conditions studied

- HIV I Infection

## Interventions

- **OTHER:** Model of care delivery for long-acting injectable ART

## Key facts

- **NCT ID:** NCT06635421
- **Lead sponsor:** MetroHealth Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2024-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06635421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06635421, "The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06635421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*